Vanguard Group Inc Clear Point Neuro, Inc. Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
A detailed history of Vanguard Group Inc transactions in Clear Point Neuro, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,242,993 shares of CLPT stock, worth $18.2 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,242,993
Previous 1,216,366
2.19%
Holding current value
$18.2 Million
Previous $6.56 Million
112.52%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding CLPT
# of Institutions
83Shares Held
6.81MCall Options Held
84.3KPut Options Held
56.7K-
Essex Investment Management CO LLC Boston, MA464KShares$6.79 Million0.97% of portfolio
-
Taylor Frigon Capital Management LLC375KShares$5.48 Million2.12% of portfolio
-
Black Rock Inc. New York, NY366KShares$5.36 Million0.0% of portfolio
-
Brown Advisory Inc333KShares$4.88 Million0.0% of portfolio
-
Cm Management, LLC300KShares$4.39 Million2.82% of portfolio
About ClearPoint Neuro, Inc.
- Ticker CLPT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 24,488,300
- Market Cap $358M
- Description
- ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. The company develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under direct, and intra-procedural magnetic resonance imaging (MRI) guidance. It offers ClearPoint system for the insertion of deep brain ...